1190379-37-3
Chemical Structure
MRT 68601
- CAS. Nr.: 1190379-37-3
- Formula:C25H34N6O2
- Molecular Weight:450.58
IUPAC Name: N-(3-((5-cyclopropyl-2-((4-morpholinophenyl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide
InChIKey: CJPMSUUANYLPET-UHFFFAOYSA-N
SMILES: O=C(NCCCNC1=NC(NC2=CC=C(C=C2)N3CCOCC3)=NC=C1C4CC4)C5CCC5
Biological Activity: MRT 68601 is a potent TBK1 inhibitor with the activity of inhibiting autophagosome formation in lung cancer cells. MRT 68601 may have potential effects against targets associated with host-dependent factors identified in SARS-CoV-2 infection. The drug targets involved in MRT 68601 are related to existing FDA-approved drugs and compounds in clinical trials, which can provide support for the development of broad-spectrum antiviral therapies[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MRT 68601 | MRT 68601 is a potent TBK1 inhibitor with the activity of inhibiting autophagosome formation in lung cancer cells. MRT 68601 may have potential effects against targets associated with host-dependent factors identified in SARS-CoV-2 infection. The drug targets involved in MRT 68601 are related to existing FDA-approved drugs and compounds in clinical trials, which can provide support for the development of broad-spectrum antiviral therapies. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
